Advisor Group Holdings, Inc. Inmune Bio, Inc. Transaction History
Advisor Group Holdings, Inc.
- $43.4 Billion
- Q1 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 12,270 shares of INMB stock, worth $99,018. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,270
Previous 10,700
14.67%
Holding current value
$99,018
Previous $120,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding INMB
# of Institutions
57Shares Held
2.88MCall Options Held
44.6KPut Options Held
3.5K-
Vanguard Group Inc Valley Forge, PA541KShares$4.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY240KShares$1.94 Million0.0% of portfolio
-
Mai Capital Management181KShares$1.46 Million0.02% of portfolio
-
Rhenman & Partners Asset Management Ab Stockholm, V7178KShares$1.44 Million0.2% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$1.38 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $145M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...